PGFC
KALA icon

Peapack-Gladstone Financial Corp’s KALA BIO KALA Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$3K – 694
2022
Q3 		$3K Hold
5
– – ﹤0.01% 683
2022
Q2 		$4K Buy
+5
New +$7.84K ﹤0.01% 653

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Peapack-Gladstone Financial Corp's KALA Position: Q4 2022 in Review

Peapack-Gladstone Financial Corp sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 5 shares — an estimated $3K sold.

Peapack-Gladstone Financial Corp first reported a position in KALA in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Peapack-Gladstone Financial Corp reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 5 KALA BIO shares in Q4 2022, an estimated $3K.
  • Peapack-Gladstone Financial Corp first reported a position in KALA BIO in Q2 2022 and held it in 2 quarters.
  • Peapack-Gladstone Financial Corp's KALA BIO position peaked at $4K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q4 2022, filed 14 Feb 2023.